In cancer cells, PTK6 promotes oncogenic signaling at the membrane and in the cytoplasm through interactions with growth factor receptors and cytoplasmic substrates such as IRS4, paxillin, STATs, (reviewed in [1], [22]), and AKT [40]. The gene discussed is IRS4; the disease is cancer.